Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
editorial
. 1999 Jun;37(6):2118–2119. doi: 10.1128/jcm.37.6.2118-2119.1999

Treatment Strategies for Group A Streptococcal Pharyngitis

James A Kellogg 1
PMCID: PMC85060  PMID: 10383261

In the recent, nicely done study by Needham et al. (2) concerning the impact of a rapid group A streptococcal antigen assay on physician usage of appropriate antibiotics, there are two areas of concern.

(i) In the abstract, the authors state that if the rapid antigen test alone had guided therapeutic choice, an appropriate course of antibiotics would have been prescribed for 95% of the patients during the initial visit. In their conclusion, last paragraph, the authors further state that neither the clinical assessment of the patients by their physicians nor culture added significantly to the improved outcome (i.e., appropriately using or withholding antibiotics) and that the preferred strategy was exclusive reliance on the rapid antigen test. While it is true that 95% of the total number of culture-positive and -negative patients would have been appropriately treated or not treated if the decision to treat had been based solely on antigen assay results, 15 (12.9%) of their 116 culture-positive patients (the target population for the diagnostic tests) would not have been treated if this strategy had been followed because their antigen test results were falsely negative. This is an unacceptably high rate of diagnostic failures and treatment errors.

In order to prevent the suppurative and nonsuppurative streptococcal sequelae mentioned in the work by Needham et al. (2), as well as to avoid unnecessary therapy, it still appears that a more effective treatment strategy would be to (a) treat all of those with positive antigen results and withhold therapy from as many as clinically possible of the rest pending culture results (since neither antigen assays nor culture can claim 100% sensitivity, the diagnosis of group A streptococcal pharyngitis should include both clinical and epidemiologic findings [3]), (b) perform cultures for all patients with negative streptococcal antigen results, and (c) treat the antigen-negative, culture-positive patients as currently recommended (3).

(ii) The authors reported that 11 of the 15 false-negative antigen test results came from patients whose cultures contained only rare to few colonies of group A streptococci (2). The implication may be that those patients with small numbers of streptococcal colonies from culture are only colonized, not infected. This interpretation would be in direct conflict with the conclusion of an excellent study by Gerber et al. (1) that found that the differentiation of patients with streptococcal infections from those who are only carriers of the organism could not be made on the basis of the degree of positivity of the culture alone.

TABLE 1.

Diagnostic tests performed and complications during each time period

Descriptor No. of pharyngitis patients during:
P
Period 1a Period 2b
Diagnostic test(s) 15,399 14,637
 Throat culture 10,098 2,087 <0.001
 Antigen test 8 7,434 <0.001
 Antigen test + culture 1 184
 No test 5,292 4,932
Suppurative complications 56 43  NSc
 Peritonsillar abscess or cellulitis 34 35
 Retropharyngeal abscess 3 1
 Pharyngitis and lymphadenitis 19 7
Nonsuppurative complications 0 1 NS
 Acute rheumatic fever 0 0
 Post-streptococcal infection glomerulonephritis 0 1
a

1 April 1994 to 31 March 1996. 

b

1 April 1996 to 31 March 1998. 

c

NS, not significant. 

REFERENCES

  • 1.Gerber M A, Randolph M F, Chanatry J, Wright L L, DeMeo K K, Anderson L R. Antigen detection test for streptococcal pharyngitis: evaluation of sensitivity with respect to true infections. J Pediatr. 1986;108:654–658. doi: 10.1016/s0022-3476(86)81036-8. [DOI] [PubMed] [Google Scholar]
  • 2.Needham C A, McPherson K A, Webb K H. Streptococcal pharyngitis: impact of a high-sensitivity antigen test on physician outcome. J Clin Microbiol. 1998;36:3468–3473. doi: 10.1128/jcm.36.12.3468-3473.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Schwartz B, Marcy S M, Phillips W R, Gerber M A, Dowell S F. Pharyngitis—principles of judicious use of antimicrobial agents. Pediatrics. 1998;101(Suppl.):171–174. [Google Scholar]
J Clin Microbiol. 1999 Jun;37(6):2118–2119.

AUTHORS’ REPLY

Cynthia A Needham 1,2, Kenneth A McPherson 1,2, Kenneth H Webb 1,2

We appreciate Dr. Kellogg’s careful reading of our paper. He raises a very important concern with regard to long-term complications that might be associated with use of the STREP A OIA test without culture confirmation.

After the introduction of point-of-care testing without reflexive culture confirmation at the Lahey Clinic, we attempted to answer questions about long-term patient outcome using the Lahey Clinic’s Decision Support System. Using ICD-9 codes for diagnoses and CPT codes for testing, we identified 30,036 patients with a primary diagnosis of pharyngitis managed during a 4-year period (data are summarized in Table 1). The Lahey group practice saw about half of the patients (15,399) in the 2 years preceding the introduction of the OIA test (period 1). They saw the remainder of the patients (14,637) in the 2 years following the introduction of the OIA test (period 2).

During period 1, physicians ordered throat cultures for 65.6% of patient encounters, using no tests in the other 34.4%. During period 2, physicians ordered the OIA test as the sole test in 50.8% of patient encounters, a throat culture as the sole test in 14.3% of patient encounters, the OIA test with culture confirmation in 1.3% of patient encounters, and no test in the remaining 33.7%. This change in diagnostic strategy was statistically significant (P < 0.001).

Using ICD-9 codes for suppurative and nonsuppurative complications of pharyngitis and chart review, we found no significant difference between the numbers of patients with complications during the two periods. Analysis of period 1 identified 56 patients with peritonsillar abscess, retropharyngeal abscess, or cervical lymphadenitis. Analysis of period 2 identified 43 patients with a similar distribution of suppurative complications. No patient was diagnosed as having acute rheumatic fever during either period.

We concluded that providing a point-of-care test with characteristics equivalent to the STREP A OIA test without culture confirmation improves patient management without sacrificing long-term quality of care. We were able to achieve improved short-term patient outcome, increasing the number of patients treated appropriately during their physician encounter. We increased the number of patients with group A streptococci (GAS) who received a prescription for a full 10-day course of therapy at the time of their visit. We decreased the number of patients without GAS who received a prescription for an unnecessary antibiotic. We also demonstrated no change in long-term outcome associated with this system-wide change in diagnostic strategy.


Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES